SUMMARY A retrospective analysis has been made of patients who had been classified (on the basis of measurements of serum thyroxine and thyroid hormone uptake test) as equivocal thyrotoxic (273 patients) or as equivocal hypothyroid (352 patients). The final diagnosis of these patients has been traced from their medical records. The results illustrate that control groups of euthyroid, thyrotoxic, and primary hypothyroid subjects differ from these equivocal groups. The populations initially classified as equivocal have been used to redefine the combinations of values obtained in the serum thyroxine and thyroid hormone uptake test which must be classed as equivocal. Using this redefinition, it is shown that a number of additional tests had been carried out when it could now be predicted with confidence that no useful new information would be obtained. The procedure described is not limited to tests of thyroid function and could easily be applied in most laboratories to redefine the ranges of results classified as equivocal.
One of the problems associated with the use of biochemical tests as an aid to clinical diagnosis is that there is often overlap in the values obtained from normal and from abnormal subjects. This overlap gives rise to a group of results or subjects which can be described as equivocal. In some cases, such as in the diagnosis of thyroid disease, an equivocal result from an initial screening test can be backed up by a more specific test. Such a strategy has been well described;' 3 and the principle of using first-line and second-line tests is likely to continue even though new tests may replace the ones in current common usage. In view of the financial and other resources needed to carry out these tests;" it is important to limit their number as much as possible. In practice, this requires that limits be set to the equivocal range which are as narrow as possible without significant risk that an abnormal subject is placed in the normal group (and therefore not treated) or a normal subject placed in the abnormal group (and therefore treated unnecessarily).
One of the difficulties of defining the equivocal group stems from the practice of determining the Serum thyroxine was measured, until 1977, by a range of values expected in any given test by reference resin binding technique with a kit supplied by Oxford to control populations of subjects carefully selected Laboratories Ltd, and subsequently by radioas either euthyroid, thyrotoxic, or hypothyroid. The immunoassay with a kit supplied by Corning problem of discriminating between these populations Medical. In our hands, these methods give indisis not the same as that of detecting euthyroid subjects tinguishable results when the same sample is in a population already suspected on clinical grounds assayed by both methods.
Thyroid hormone uptake was measured by a modification of the method described by Herbert et al. 7 Serum triiodothyronine was measured by radioimmunoassay with a kit supplied by the Radiochemical Centre, Amersham.
Serum thyroid stimulating hormone (TSH) was measured by radioimmunoassay with a kit supplied by either Pharmacia (GB) Ltd or Corning Medical.
Free thyroxine index (FTI) was calculated as 100 times the ratio of serum thyroxine to thyroid hormone uptake.
Subjects studied
CONTROL POPULATIONS Blood samples were obtained from control populations of IS3 normal, 81 newly diagnosed thyrotoxic, and 76 newly diagnosed hypothyroid subjects. The normal group were healthy blood donors, SS men and 98 women (age range 18-6S years). The thyrotoxic group were selected retrospectively from a group of95 consecutive new and previously untreated patients attending a special thyroid clinic. All the patients were assessed by the Wayne index. Wherever there was biochemical or clinical doubt, thyroid status was defined by a thyrotrophin releasing hormone test. All 7 men and 74 women selected (age range 17-84 years) responded to treatment. The hypothyroid group were selected retrospectively from a group of 98 newly diagnosed and previously untreated patients attending the outpatient department. All 17 men and 59 women selected (age range 39-84 years) had signs and symptoms of hypothyroidism and a level of TSH at diagnosis of more than IS mUll, which fell to less than 10 mUll within six months of treatment,
EQUIVOCAL POPULATIONS
We have examined the results of 10 600 thyroid screen tests carried out in the laboratory over a three-year period. Seven hundred and five subjects were identified, for each of whom the physician had Barnard, Bingle, and Garratt requested either a TSH or a triiodothyronine test on the grounds that he was unable to classify the subject's thyroid status without this additional information. Of these equivocal subjects, 399 were on the hypothyroid side of normal (equivocal hypothyroid) and 306 were equivocal thyrotoxic. The final diagnosis of 47 men and 305 women (age range 21-95 years) from the equivocal hypothyroid group was traced, and also for 41 men and 232 women (age range 17-80 years) from the equivocal thyrotoxic group. This analysis provided us with four groups of unequivocally diagnosed subjects who had originally been classified as equivocal and the values of whose serum thyroxine and thyroid hormone uptake test were known. The numbers in each group were as follows: 106 hypothyroid; 94 thyrotoxic; 246 euthyroid from the equivocal hypothyroid group; and 179 euthyroid from the equivocal thyrotoxic group.
The scattergram obtained when the results of the measurements of serum thyroxine and the thyroid hormone uptake test from the patients originally classified as equivocal thyrotoxic or equivocal hypothyroid are plotted on a map relating the two parameters is shown (Figure) . Because of the difficulty of plotting all 625 data points, every second subject has been omitted from this plot.
VALUES OF SERUM THYROXINE AND THYROID HORMONE BINDING INDEX
It has generally been assumed that a gaussian distribution of values is obtained for the serum thyroxine from control euthyroid populations." We find, however, that only the values of thyroid hormone uptake test from our control euthyroid population have an approximately gaussian distribution. The values for the serum thyroxine have a clearly skewed distribution such that the logarithms of the values approximate more closely to a gaussian distribution than do the values themselves. This means that the values we obtain for the FfI are similarly skewed. Table 1 shows the mean values and their standard deviations (calculated by the con- The essential features of discriminant analysis are most easily appreciated from the consideration of discrimination based on two parameters (such as those used for the thyroid screen). A scattergram such as that shown in the Figure is prepared so that each individual can be positioned at a point fixed by the observed values of serum thyroxine and thyroid hormone binding index. Discriminant analysis is then applied to the paired values obtained from the control populations known to be different. This procedure defines the straight line on the map which divides these two populations with the minimum chance of misclassification. The position of each subject relative to this line is defined by a 'z-value,' which can be calculated for any subject with known levels of the two parameters. A value Zo is also defined such that the values of z greater than Zo fall on one side of the discriminant line and values less than Zo on the other. Discriminant analysis based on three, four or n parameters deals with the problem in the same way but in three, four, or n dimensions.
DISCRIMINANT ANALYSIS ON CONTROL POPULATIONS
All five measurements of thyroid function were made on blood samples from all subjects in each group of control subjects. Discriminant analysis has been applied to different combinations of these measurements. It was found that only six of the 304 subjects were incorrectly classified when the procedure was applied to measurements of serum thyroxine and thyroid hormone uptake test (see Table 2 ). Other combinations of tests gave insignificant improvements compared with the increased cost of tests. This confirms that these two measurements provide the most effective primary screen for distinguishing euthyroid subjects from control populations of thyrotoxic and hypothyroid subjects. A value of ZO(T) was calculated for the control groups of thyrotoxic and euthyroid subjects and was found to be 0·0769. It follows that individual z values of thyrotoxic and euthyroid subjects are expected to be respectively higher than and lower than this value. Similarly, a value of ZO(H) was calculated for the control group of hypothyroid and the same euthyroid subjects. It was found to be O'0593 so that z values of hypothyroid and euthyroid subjects are expected to be respectively lower than and higher than this value.
This analysis can be shown graphically on a scattergram which has two discriminant lines dividing the map into three segments,"
CLASSIFICATION OF EQ UIVOCAL POPULATIONS
The equivocal thyrotoxic and the equivocal hypothyroid subjects were assigned to euthyroid or abnormal categories on the basis of the values for ZO(T) and ZO(H) . This led to misclassification of 188 of the 625 subjects, as shown in Table 2 and illustrates that, although there is comparatively little overlap between control populations of thyrotoxic, euthyroid, and hypothyroid subjects, a large number of misclassifications can arise in a population which is preselected for being equivocal.
Definition ofequivocal groups
Because there is overlap of the euthyroid population with both the hypothyroid and thyrotoxic groups, it is necessary to define equivocal populations. In the interests of economy these equivocal populations must be as small as is consistent with a negligible incidence of misclassification. The problem is therefore to define the minimum area of overlap on the scattergram of results shown in the Figure. It is a reasonable assumption that the data from any population could be circumscribed by orbiculate contours such that each contour had a given probability of enclosing individuals of that population. The equivocal populations would then be defined by the overlapping regions of these contours.
Eliptical contours could be calculated from the confidence limits of the serum thyroxine and the thyroid hormone uptake test provided that the values themselves were normally distributed. This would be calculated from the mean value for each parameter (x and )I) and their confidence limits (ex and ey). The four points defined by the combinations of x with ji ± ey and ji with x ± ex form the corners of a parallelogram around which a unique elipse could be drawn. However the equation for calculating the elipse is not only cumbersome but actually inappropriate since the values we have obtained are not normally distributed. This means that the four points defined above do not form the corners of a parallelogram but of an irregular tetrahedron. A practical solution to the problem is to use two of the sides of the tetrahedron to define the limits of the population. These two lines have equations
The control populations of thyrotoxic, euthyroid, and hypothyroid subjects are of only limited value in calculating these lines. This is because the population on whom diagnosis is being carried out is significantly different from the control populations so that a comparatively large fraction of them will fall outside the 99 %confidence limits of the appropriate control populations. It is therefore necessary to define the limiting values of each population by reference to the subjects who were diagnosed as equivocal after the initial thyroid screen and retrospectively classified into four populations. The equivocal thyrotoxic Barnard, Bingle, and Garratt group is then defined by values which fall between the lower limit of the thyrotoxic group (line 3, Figure) and the upper limit of the euthyroid from equivocal thyrotoxic group (line 4, Figure) . The equivocal hypothyroid group is defined by values which fall between the upper limit of the hypothyroid population (line 2, Figure) and the lower limit of the euthyroid from equivocal hypothyroid group (line 1, Figure) .
This procedure has the advantage of being objective and we have been unable to find a better objective method. However we are not satisfied that its objectivity is a significant benefit since it is based on untested assumptions about the pattern of experimental data. We therefore see no reason why the limiting lines should not be drawn by eye provided that some attempt is made to estimate the extent of misclassification that will result. This is the approach that we have adopted.
USE AND EFFECTIVENESS OF DISCRIMINANT (d) VALUES
Once the position of each line has been established the classification of a subject is determined from the calculation of four discriminating or 'd-values' (one with respect to each line). The d-value is the shortest distance from a particular line to the point defined by the two measurements from a given subject. It is easy to show by simple geometry that this distance can be calculated (using equation 2) from the slope (m) and the intercept (c) of the line, the serum thyroxine level (y) and the thyroid hormone uptake test (x) .
If a d-value is positive the subject lies above a particular line. Thus a subject with a d-value which is negative with respect to line 4 but positive with respect to line 3 lies between line 3 and line 4 in the equivocal thyrotoxic segment. We have used the lines drawn by eye and shown in the Figure to calculate a series of d-values for each of the four populations derived from the equivocal groups. We have examined these sets of d values with a view to predicting the probability of finding a negative value. This probability should be negligible for the thyrotoxic and the euthyroid from the equivocal hypothyroid populations but close to one for the hypothyroid and the euthyroid from the equivocal thyrotoxic populations. The estimation of these probabilities is made difficult since neither the dvalues nor any simple function of them show a normal distribution. We have therefore plotted the results on probability paper according to the convention of Anscombe and Tukey" and used the resulting graphs to estimate the probability of finding a negative d-value. In this way we have estimated that the lines we have finally chosen will result in misdiagnosis in less than I %of cases.
As a check of the effectiveness of our lines we have, over a two-month period, calculated d-values for all the subjects on whom a triiodothyronine or a thyroid stimulating hormone test was requested at the same time as the thyroid screen. During this period we made 52 measurements of triiodo thyronine. Of these 31 were on subjects who would be classified as equivocal on the basis of the d-value; 19 of the rest would have been classified as euthyroid and two as thyrotoxic. Among the 19 subjects who would have been judged as euthyroid we found two with raised levels of triiodothyronine (above 3· 1 nrnol/l), neither of which was associated with thyroid dysfunction. Both the subjects who would have been classed as thyrotoxic had raised levels of triiodo thyronine. Thus this measurement gave no useful information on the 40 %of subjects already classified by d-values as being either euthyroid or thyrotoxic. Of the 31 equivocal subjects, however, we found that 22 had raised values of triiodothyronine and nine had normal values.
Over the same period we have made 210 measurements of TSH; 164 were on subjects classified by d-values as normal, 34 as equivocal, and 12 as hypothyroid. Of the 34 subjects on whom we considered further tests to be justifiable, we found 17 with raised levels of TSH (greater than 15 mU /1) and 17 with normal levels. Among the 164 subjects who would have been judged as euthyroid on the basis of a d-value we found no raised levels of TSH. All 12 classified as hypothyroid were found to have raised levels. After this trial the procedure described here was adopted for general use at the York District Hospital. Only in exceptional cases are further tests of thyroid function carried out on subjects whose d-values do not fall in the equivocal range.
Conclusion
Inspection of the data in the Figure shows that 60 out of 273 measurements of triiodothyronine and 117 out of 352 measurements of TSH would be classed as unnecessary by our new approach. Furthermore, it is our impression that the number of unwarranted tests was on the increase when we introduced this procedure. We therefore estimate that we have achieved a saving of at least 35 %of these tests.
We do not suggest that this procedure should be used to prevent a clinician from asking for second tests when there are other indications that these tests might provide useful information, but it can be used to limit the range of results obtained (from any biochemical test) that should be classified as equivocal. All that is required is access to records from which a retrospective analysis of equivocal results can be carried out. We suggest that it is in principle more valuable to define equivocal ranges by such a retrospective analysis than to spend effort defining the normal ranges of values found in control populations.
